Biodesix Inc (BDSX)
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
$26.18-1.13%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Diagnostics & ResearchSnapshot 2026-09-04
QuarterlyIQ Insights · BDSX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 102.9 | 88.5 | 71.3 | 49.1 | 38.2 | 54.5 | 45.6 |
| Total Revenues | 102.9 | 88.5 | 71.3 | 49.1 | 38.2 | 54.5 | 45.6 |
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 93.2 | 87.5 | 80.5 | 67.4 | 61.5 | 50.5 | 34.9 |
| R&D Expenses | 12.3 | 12.0 | 9.6 | 10.0 | 13.1 | 12.8 | 10.8 |
| Operating Income | (20.6) | (27.9) | (34.5) | (41.3) | (50.6) | (40.9) | (22.9) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | 8.1 | 7.7 | 8.3 | 9.5 | 8.1 | 4.5 | 7.6 |
| Other Non-Operating Income / Expenses | (7.2) | (7.4) | (8.4) | (10.8) | — | — | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||
| Net Income | (27.8) | (35.3) | (42.9) | (52.1) | (65.4) | (43.2) | (65.4) |
| Per Share | |||||||
| Basic EPS | (2.70) | (4.67) | (0.33) | (0.64) | (1.55) | (1.58) | — |
| Diluted EPS | (2.70) | (4.67) | (0.33) | (0.64) | (1.55) | (1.58) | — |
| Revenue per Share | 10.00 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 10.3 | 7.6 | 129.7 | 82.1 | 42.1 | 27.4 | — |
| Diluted Weighted Avg Shares | 10.3 | 7.6 | 129.7 | 82.1 | 42.1 | 27.4 | — |
| Supplemental | |||||||
| EBITDA | — | (22.2) | (28.7) | (38.0) | (47.0) | (37.8) | (20.0) |
| EBIT | (20.6) | (27.9) | (34.5) | (41.3) | (50.6) | (40.9) | (22.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.